| COMPANY |
Humana Inc. |
| COURT |
United States District Court for the District of Delaware |
| CASE NUMBER |
1:24-cv-00655-JLH |
| JUDGE |
The Hon. Jennifer L. Hall |
| CLASS PERIOD |
July 27, 2022, through October 1, 2024 |
| SECURITY TYPE |
Securities |
Case Background:
This is a class action lawsuit behalf of those who purchased or acquired Humana Inc. (“Humana”) (NYSE: HUM) common stock between July 27, 2022, and October 1, 2024, both dates inclusive (the “Class Period”).
The Complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company’s business and operations. Specifically, Defendants downplayed pressures on the Company’s adjusted EPS resulting from increased medical costs associated with pent-up demand for healthcare procedures (especially as COVID concerns abated) which, contrary to the Company’s assurances, resulted in increased utilization rates and costs.
Current Status of Case:
On September 13, 2024, the Court entered an Order Appointing SEB Investment Management AB as Lead Plaintiff and Approving Kessler Topaz Meltzer & Check, LLP as Lead Counsel. Lead Plaintiff filed an Amended Complaint on November 20, 2024. This action is ongoing.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.